Coeptis Therapeutics Holdings, Inc. (COEP)의 가격은 얼마입니까?

Coeptis Therapeutics Holdings, Inc. (COEP)의 가격은 $4.81입니다.

Coeptis Therapeutics Holdings, Inc. (COEP)의 시가 총액은 무엇입니까?

Coeptis Therapeutics Holdings, Inc. (COEP)의 시가 총액은 $29.01M입니다.

Coeptis Therapeutics Holdings, Inc. (COEP) 발행주식수

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company’s product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze cancer patients if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a chimeric antigen receptor (CAR) therapy for treatment for cancer. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

연도	발행 주식 수	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

발행 주식 수

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	발행 주식 수	차이	국가
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Moderna, Inc. MRNA.US	396.00M	-	US
Argenx SE ARGX.US	62.19M	-	NL
CSL Limited CSL.AX	483.58M	-	AU
Lonza Group AG LONN.SW	-	-	CH

회사

발행 주식 수

차이

국가